methyl 1-acetyl-2-hydroxy-1H-indole-6-carboxylate, 98%, 250mg

Hidroxiamantanona, mínimo 98 %, para síntesis, 1 g, envase de vidrio

5,7-Dichloro-3-methyl-3H-imidazo[4,5-b]pyridine, 95%, 1g

trans-2,4-Difluorocinnamic acid, 98.0%, 100g

6-BROMO-8-IODOIMIDAZO[1,2-A]PYRIDINE, 95.0%, 25g

1-(2-Bromophenyl)ethylamine, 95.0%, 250mg

3-(methylamino)-3-oxopropanoic acid, 95.0%, 5g

ETHYL 3,6-DIBROMOPYRAZINE-2-CARBOXYLATE, 95.0%, 5g

1-Isopropyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indol-6-amine, 97%, 250mg

Cycloheptane-1,3-dione, 97.0%, 25g

2-CHLORO-5-(1-METHYL-PIPERIDIN-4-YLMETHOXY)-PYRIMIDINE, 95.0%, 500mg

4-Amino-5-bromonicotinic acid, 95.0%, 250mg

4,5,6-TRIMETHOXY-1H-INDOLE, 95.0%, 1g